Novartis

Novartis is a multinational pharmaceutical company that researches, develops, manufactures, and sells prescription and generic medicines. It operates across various therapeutic areas, including oncology, immunology, cardiology, and neuroscience.

Why it’s in the news: It is in the news due to multiple high-profile drug trial failures and investor concerns over patent expirations.

Latest on Novartis

• STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
• STAT+: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more
• STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
• STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
• Novartis’s failed trial for cholesterol drug leads to broad biopharma selloff
• STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company

Connections

9 entities linked to Novartis across the news graph.